Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. SHC is recognized by U.S. News & World Report as one of "America's Best Hospitals," currently ranked #10 in the U.S on the Best Hospitals Honor Roll and #15 as the Best Hospitals for Cancer. Stanford Cancer Institute has been a National Cancer Institute (NCI) Designated Cancer Center since 2007 and is a National Comprehensive Cancer Network (NCCN) founding member. Annually, there are over 600 accruals to interventional treatment clinical trials.
The Hematology/Oncology Residency at SHC is a 12-month PGY2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center. Two applicants are accepted per year.
The program is designed to transition PGY1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming full responsibility for optimizing patient care as an oncology pharmacist.
Throughout the program, the resident will gain practical experience in the management in neoplastic diseases as well as cancer-related and cancer treatment-related disorders. Due to the prominent use of investigational drugs in the treatment of cancer, the resident will also gain the knowledge and skills necessary to practice effectively in clinical research environments. The resident will be able to manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Experiences will also include leadership in formulary decision-making for cancer-related medications.
Trained for practice leadership, the PGY2 Hematology/Oncology residents will be able to successfully serve health care organizations with the clinical and practice skills necessary for effective decision-making in the treatment of oncologic and hematologic disorders.
Residency Contact Information
Residency Program Director: Edna Cheung, PharmD, BCOP
Stanford Health Care
Department of Pharmacy
500 Pasteur Drive, Room J010
Stanford, CA 94304
The mission of the PGY2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, develop clinical skills and knowledge in evidence-based medicine, and prepare for a comprehensive practice in hematology/oncology in clinical, administrative, research, and/or academic settings. Upon completion of the residency program, the resident will:
Provide optimal clinical care to patients with oncologic and/or hematologic disorders
Function independently as an effective member of the health care team
Educate health care professionals, students, patients, and the community about effective and safe medication use
Establish a practice change based on a completed research project
Develop excellent written and verbal communication skills
Demonstrate time management and problem-solving skills
Become a leader within the pharmacy profession
The Hematology/Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.
*In general, a maximum of one off-site rotation is permitted
Outpatient Hematology/Oncology/BMT Clinics
Independent research project presented at a national conference
Residency research seminars
Active participation in interdisciplinary patient care rounds
Comprehensive patient care, including patient counseling and education
Education to pharmacy, medical, and nursing staff as well as PGY1 pharmacy residents and students
Hematology/oncology drug monograph and medication use evaluation presented to P&T Committee
Hematology/oncology related committee meetings and teaching sessions
Journal club and forum presentations, including a CAPE-accredited CE and a clinical debate
Chemotherapy preparation and dispensing
Staff 16 hours every 3 weeks in the inpatient hematology/oncology/BMT pharmacy satellites
Compensation and Benefits
PGY-2 residents receive a competitive annual stipend of approximately $81,000 with full benefits, including an excellent health care benefits package and 10 days paid time off (PTO). In addition, the PGY-2 resident will enjoy educational leave and a stipend to attend and participate at various pharmacy conferences throughout the year.
Completion of Doctor of Pharmacy degree from an ACPE-accredited school or college of pharmacy
Completion of an ASHP-accredited PGY1 residency program
Participate in interview at Stanford Health Care (on-site vs virtual depending on pandemic situation)
Obtain licensure to practice pharmacy in the state of California prior to October 1
See Application Process for additional details
Chananid (Sun) Laikijrung
Sun received her Bachelor of Science in Biochemistry from the University of California of Los Angeles (UCLA) and Doctor of Pharmacy from the University of California, San Francisco (UCSF). She completed PGY-1 pharmacy residency at Stanford Health Care. Her professional interests include bone marrow transplant, cellular therapy, and immunotherapy. In her free time, Sun enjoys cooking, hiking, and doing arts and crafts.
Kaitlyn Van Peursem
Kaitlyn received her Bachelor of Science degree in Pharmacological Chemistry from the University of California, San Diego and Doctor of Pharmacy degree from the University of North Carolina Eshelman School of Pharmacy. She then completed her PGY-1 Acute Care Pharmacy Residency at Stanford Health Care. Her professional interests within oncology include hematology, bone marrow transplant, and immunocompromised infectious diseases. In her free time, Kaitlyn enjoys long runs, playing with her puppy, and being outside in the sunshine.